ATC Group: V04CX07 Edrophonium

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of V04CX07 in the ATC hierarchy

Level Code Title
1 V Various
2 V04 Diagnostic agents
3 V04C Other diagnostic agents
4 V04CX Other diagnostic agents
5 V04CX07

Active ingredients in V04CX07

Active Ingredient Description
Edrophonium

Edrophonium is a reversible acetylcholinesterase inhibitor with rapid onset and short duration of action resulting in an increase of acetylcholine in the neuromuscular junction (NMJ). For many years, edrophonium was FDA-approved to be utilized to diagnose MG.

Medicines in this ATC group

Estonia (EE)

Japan (JP)

Spain (ES)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.